Abstract:
Small Gilligan molecules bind to DNA and artificially alter and/or inhibit the functioning of DNA. These small ligand molecules act as drug when alteration or inhibition of DNA function is required to cure or control a disease.The binding interaction of N-phenyllauroylhydroxamic acid with CTDNA was measured by four methods, (i) UV spectroscopic method, (ii) fluorescence spectroscopic method, (iii) viscosity Measurement and (iv) molecular docking. It showed that Nphenyllauroylhydroxamic acid-DNA complex has high absorption intensity than compound only and significant quenching of fluorescence intensity for the N-phenyllauroylhydroxamic-DNA complex. The values of binding constant, K, is 3.43x 10-2nd Stern Volmer constant Ksv is 4.8 x102 ng-1μl obtained by UV absorption and fluorescence spectral methods, respectively. The binding interaction is further confirmed by the increase in relative viscosity of CT-DNA. The molecular docking of N-phenyllauroylhydroxamic acid with the DNA confirmed to be a strong binder with DNA in the mode of groove.
